In a report released today, Joon Lee from Truist Financial assigned a Buy rating to Corcept Therapeutics (CORT – Research Report). The ...

Naturally 7 last performed as part of the Poway OnStage season in February 2022. All the songs the group has planned for their 7:30 p.m. show on Saturday, Sept. 21 come from movies except for the ...

Cort Guitars launches the Artisan C Deluxe Bass Guitar Series, available in both 4-string or 5-string. Cort, founded in 1960, ...

Corcept Therapeutics (CORT) shares soared 6.5% in the last trading session to close at $42.27. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $50.17, ...

Dozens of online school threats have been made in districts across the state and the Valley, including schools nearby in ...

James "Jim" "Duke" DeWayne Motter, 79, passed away September 16, 2024 at his residence. Jim was born June 20, 1945 in Bluffton to the late Myron and Edith (Zimmerly) Motter. On October 11, 1968 he ...

Buy CORT near 38.11 target n/a stop loss @ 38. Details The technical summary data tells us to buy CORT near 38.11, but there is no current upside target from the summary table. In this case we should ...

Corcept is a profitable biotech company with significant potential for growth, focusing on treating Cushing's Syndrome and ...

Truist has recently raised Corcept Therapeutics Incorporated (CORT) stock to Buy rating, as announced on November 6, 2023, according to Finviz. Earlier, on April 11, 2023, SVB Securities had initiated ...

Once you pick it up, you’ll know right away that this is a serious and worthy electric that should be on your radar,” Guitar ...

UW-Green Bay gave people a look at its new Cort Condon Hall at a dedication ceremony and open house Tuesday afternoon.